-
A.
Ogunniyi,
Matthew
Woodrow,
J.
Poolman,
J.
Paton
(2001)
Protection against Streptococcus pneumoniae Elicited by Immunization with Pneumolysin and CbpA
Infection and Immunity, 69
-
E.
Oloo,
J.
Yethon,
M.
Ochs,
B.
Carpick,
R.
Oomen
(2011)
Structure-guided Antigen Engineering Yields Pneumolysin Mutants Suitable for Vaccination against Pneumococcal Disease
The Journal of Biological Chemistry, 286
-
L.
Bakaletz
(2007)
Bacterial Biofilms in Otitis Media: Evidence and Relevance
The Pediatric Infectious Disease Journal, 26
-
Soininen
(2002)
Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children
Clin Diagn Lab Immunol, 9
-
S.
Comis,
M.
Osborne,
J.
Stephen,
M.
Tarlow,
T.
Hayward,
T.
Mitchell,
P.
Andrew,
G.
Boulnois
(1993)
Cytotoxic effects on hair cells of guinea pig cochlea produced by pneumolysin, the thiol activated toxin of Streptococcus pneumoniae.
Acta oto-laryngologica, 113 2
-
R.
Malley,
P.
Anderson
(2012)
Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity
Proceedings of the National Academy of Sciences, 109
-
B.
Mann,
Justin
Thornton,
R.
Heath,
K.
Wade,
R.
Tweten,
G.
Gao,
K.
Kasmi,
J.
Jordan,
Diana
Mitrea,
R.
Kriwacki,
J.
Maisonneuve,
M.
Alderson,
E.
Tuomanen
(2014)
Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein.
The Journal of infectious diseases, 209 7
-
A.
Roche,
S.
King,
J.
Weiser
(2007)
Live Attenuated Streptococcus pneumoniae Strains Induce Serotype-Independent Mucosal and Systemic Protection in Mice
Infection and Immunity, 75
-
Daniel
Musher,
H.
Phan,
David
Watson,
R.
Baughn
(2000)
Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia.
The Journal of infectious diseases, 182 1
-
L.
Kirkham,
A.
Kerr,
G.
Douce,
G.
Paterson,
D.
Dilts,
Dai-Fang
Liu,
T.
Mitchell
(2006)
Construction and Immunological Characterization of a Novel Nontoxic Protective Pneumolysin Mutant for Use in Future Pneumococcal Vaccines
Infection and Immunity, 74
-
Qingfu
Xu,
J.
Casey,
M.
Pichichero
(2015)
Higher Levels of Mucosal Antibody to Pneumococcal Vaccine Candidate Proteins Are Associated with Reduced Acute Otitis Media Caused by Streptococcus pneumoniae in Young Children
Mucosal immunology, 8
-
Fortanier
(2014)
Pneumococcal conjugate vaccines for preventing otitis media
Cochrane Database Syst Rev, 2014
-
Richard
Malley,
M.
Lipsitch,
A.
Stack,
R.
Saladino,
G.
Fleisher,
Steven
Pelton,
C.
Thompson,
D.
Briles,
P.
Anderson
(2001)
Intranasal Immunization with Killed Unencapsulated Whole Cells Prevents Colonization and Invasive Disease by Capsulated Pneumococci
Infection and Immunity, 69
-
J.
Schenkein,
Saeyoung
Park,
M.
Nahm
(2008)
Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency.
Vaccine, 26 43
-
K.
Prellner,
O.
Kalm,
G.
Harsten,
J.
Heldrup,
V.
Oxelius
(1989)
Pneumococcal serum antibody concentrations during the first three years of life: a study of otitis-prone and non-otitis-prone children.
International journal of pediatric otorhinolaryngology, 17 3
-
Zhe
Zhang,
Thomas
Clarke,
J.
Weiser
(2009)
Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice.
The Journal of clinical investigation, 119 7
-
A.
Ogunniyi,
Marcin
Grabowicz,
D.
Briles,
J.
Cook,
J.
Paton
(2006)
Development of a Vaccine against Invasive Pneumococcal Disease Based on Combinations of Virulence Proteins of Streptococcus pneumoniae
Infection and Immunity, 75
-
S.
Romero-Steiner,
C.
Frasch,
G.
Carlone,
R.
Fleck,
D.
Goldblatt,
M.
Nahm
(2006)
Use of Opsonophagocytosis for Serological Evaluation of Pneumococcal Vaccines
Clinical and Vaccine Immunology, 13
-
E.
Mitsi,
A.
Roche,
J.
Reiné,
Tonia
Zangari,
J.
Owugha,
S.
Pennington,
J.
Gritzfeld,
J.
Gritzfeld,
A.
Wright,
A.
Collins,
S.
Selm,
M.
Jonge,
Stephen
Gordon,
Stephen
Gordon,
Jeffrey
Weiser,
Jeffrey
Weiser,
Daniela
Ferreira
(2016)
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage
Mucosal immunology, 10
-
K.
Corscadden,
L.
Kirkham,
R.
Thornton,
S.
Vijayasekaran,
H.
Coates,
P.
Richmond,
S.
Wiertsema
(2013)
High pneumococcal serotype specific IgG, IgG1 and IgG2 levels in serum and the middle ear of children with recurrent acute otitis media receiving ventilation tubes.
Vaccine, 31 10
-
R.
Kaur,
J.
Casey,
M.
Pichichero
(2011)
Serum Antibody Response to Five Streptococcus pneumoniae Proteins During Acute Otitis Media in Otitis-prone and Non–otitis-prone Children
The Pediatric Infectious Disease Journal, 30
-
Jerome
Klein
(2000)
The burden of otitis media.
Vaccine, 19 Suppl 1
-
J.
Paton,
R.
Lock,
D.
Hansman
(1983)
Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae
Infection and Immunity, 40
-
J.
Alexander,
R.
Lock,
C.
Peeters,
J
Poolman,
P.
Andrew,
T.
Mitchell,
D.
Hansman,
J.
Paton
(1994)
Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae
Infection and Immunity, 62
-
Thierry
Kamtchoua,
M.
Bologa,
R.
Hopfer,
D.
Neveu,
Branda
Hu,
Xiaohua
Sheng,
Nicolas
Corde,
Catherine
Pouzet,
G.
Zimmermann,
S.
Gurunathan
(2013)
Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults.
Vaccine, 31 2
-
G.
Siber,
I.
Chang,
S.
Baker,
P.
Fernsten,
K.
O'Brien,
M.
Santosham,
K.
Klugman,
S.
Madhi,
P.
Paradiso,
R.
Kohberger
(2007)
Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
Vaccine, 25 19
-
S.
Wiertsema,
K.
Corscadden,
Eva
Mowe,
Guicheng
Zhang,
S.
Vijayasekaran,
H.
Coates,
T.
Mitchell,
W.
Thomas,
P.
Richmond,
L.
Kirkham
(2012)
IgG Responses to Pneumococcal and Haemophilus Influenzae Protein Antigens Are Not Impaired in Children with a History of Recurrent Acute Otitis Media
PLoS ONE, 7
-
S.
Rapola,
T.
Kilpi,
M.
Lahdenkari,
Mäkelä
Ph,
H.
Käyhty
(2001)
Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media
The Pediatric Infectious Disease Journal, 20
-
G.
Warnick,
J.
Benderson,
J.
Albers
(1982)
Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.
Clinical chemistry, 28 6
-
S.
Wiertsema,
L.
Kirkham,
K.
Corscadden,
Eva
Mowe,
Jacinta
Bowman,
P.
Jacoby,
R.
Francis,
S.
Vijayasekaran,
H.
Coates,
T.
Riley,
P.
Richmond
(2011)
Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
Vaccine, 29 32
-
M.
Pichichero,
J.
Casey,
A.
Almudevar
(2013)
Nonprotective Responses to Pediatric Vaccines Occur in Children Who Are Otitis Prone
The Pediatric Infectious Disease Journal, 32
-
HighWire
Press
(2008)
CLINICAL AND VACCINE IMMUNOLOGY
Clinical and Vaccine Immunology, 15
-
Daniel
Musher,
Jean
Groover,
Edward
Graviss,
R.
Baughn
(1996)
The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 22 1
-
Sharad
Sharma,
M.
Pichichero
(2013)
Cellular Immune Response in Young Children Accounts for Recurrent Acute Otitis Media
Current Allergy and Asthma Reports, 13
-
R.
Burton,
M.
Nahm
(2006)
Development and Validation of a Fourfold Multiplexed Opsonization Assay (MOPA4) for Pneumococcal Antibodies
Clinical and Vaccine Immunology, 13
-
Elizabeth
Barnett,
Stephen I.
Pelton,
H.
Cabral,
Roland
Eavey,
C.
Allen,
Michael
Cunningham,
E.
McNamara,
Jerome
Klein
(1999)
Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 29 1
-
T.
Marom,
Alai
Tan,
G.
Wilkinson,
Karen
Pierson,
J.
Freeman,
T.
Chonmaitree
(2014)
Trends in otitis media-related health care use in the United States, 2001-2011.
JAMA pediatrics, 168 1
-
Ying-Jie
Lu,
J.
Gross,
D.
Bogaert,
A.
Finn,
L.
Bagrade,
Qibo
Zhang,
J.
Kolls,
Amit
Srivastava,
A.
Lundgren,
Sophie
Forte,
C.
Thompson,
Kathleen
Harney,
P.
Anderson,
M.
Lipsitch,
R.
Malley
(2008)
Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
PLoS Pathogens, 4
-
A.
Jansen,
E.
Hak,
R.
Veenhoven,
R.
Damoiseaux,
A.
Schilder,
E.
Sanders
(2009)
Pneumococcal conjugate vaccines for preventing otitis media.
The Cochrane database of systematic reviews, 2
-
J.
Eskola,
T.
Kilpi,
A.
Palmu,
J.
Jokinen,
Mervi
Eerola,
J.
Haapakoski,
E.
Herva,
A.
Takala,
H.
Käyhty,
P.
Karma,
R.
Kohberger,
S.
Lockhart,
G.
Siber,
P.
Mäkelä
(2001)
Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
The New England journal of medicine, 344 6
-
M.
Pichichero,
R.
Kaur,
J.
Casey,
Qingfu
Xu,
A.
Almudevar,
M.
Ochs
(2012)
Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children
Human Vaccines & Immunotherapeutics, 8
-
(2009)
Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines
-
Vinay
Menon,
K.
Corscadden,
A.
Fuery,
R.
Thornton,
L.
Kirkham,
P.
Richmond,
S.
Wiertsema
(2012)
Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination.
Vaccine, 30 20
-
A.
Odutola,
Martin
Ota,
E.
Ogundare,
Martin
Antonio,
P.
Owiafe,
A.
Worwui,
Brian
Greenwood,
M.
Alderson,
M.
Traskine,
V.
Verlant,
K.
Dobbelaere,
D.
Borys
(2015)
Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study
Human Vaccines & Immunotherapeutics, 12
-
S.
Rapola,
V.
Jäntti,
R.
Haikala,
R.
Syrjänen,
G.
Carlone,
J.
Sampson,
D.
Briles,
James
Paton,
Aino
Takala,
T.
Kilpi,
H.
Käyhty
(2000)
Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.
The Journal of infectious diseases, 182 4
-
Sylvia
Taylor,
P.
Marchisio,
A.
Vergison,
J.
Harriague,
William
Hausdorff,
M.
Haggard
(2012)
Impact of Pneumococcal Conjugate Vaccination on Otitis Media: A Systematic Review
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 54
-
J.
Shak,
H.
Ludewick,
Kristen
Howery,
Fuminori
Sakai,
H.
Yi,
R.
Harvey,
J.
Paton,
K.
Klugman,
J.
Vidal
(2013)
Novel Role for the Streptococcus pneumoniae Toxin Pneumolysin in the Assembly of Biofilms
mBio, 4
-
K.
Moffitt,
R.
Malley
(2011)
Next generation pneumococcal vaccines.
Current opinion in immunology, 23 3
-
A.
Soininen,
Maijastiina
Karpala,
Sirkka-Liisa
Wahlman,
H.
Lehtonen,
H.
Käyhty
(2002)
Specificities and Opsonophagocytic Activities of Antibodies to Pneumococcal Capsular Polysaccharides in Sera of Unimmunized Young Children
Clinical and Vaccine Immunology, 9
-
B.
Simell,
A.
Nurkka,
M.
Lahdenkari,
N.
Givon‐Lavi,
H.
Käyhty,
R.
Dagan,
J.
Jokinen
(2011)
Association of Serotype-Specific Antibody Concentrations and Functional Antibody Titers with Subsequent Pneumococcal Carriage in Toddlers Immunized with a 9-Valent Pneumococcal Conjugate Vaccine
Clinical and Vaccine Immunology, 19